Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 39
Filtrar
1.
Int J Mol Med ; 53(4)2024 04.
Artigo em Inglês | MEDLINE | ID: mdl-38426579

RESUMO

SET domain bifurcated 1 (SETDB1), a pivotal histone lysine methyltransferase, is transported to the cytoplasm via a chromosome region maintenance 1 (CMR1)­dependent pathway, contributing to non­histone methylation. However, the function and underlying mechanism of cytoplasmic SETDB1 in breast cancer remain elusive. In the present study, immunohistochemistry revealed that elevated cytoplasmic SETDB1 was correlated with lymph node metastasis and more aggressive breast cancer subtypes. Functionally, wound healing and Transwell assays showed that cytoplasmic SETDB1 is key for cell migration and invasion, as well as induction of epithelial­mesenchymal transition (EMT), which was reversed by leptomycin B (LMB, a CMR1 inhibitor) treatment. Furthermore, RNA­seq and metabolite detection revealed that cytoplasmic SETDB1 was associated with metabolism pathway and elevated levels of metabolites involved in the Warburg effect, including glucose, pyruvate, lactate and ATP. Immunoblotting and reverse transcription­quantitative PCR verified that elevation of cytoplasmic SETDB1 contributed to elevation of c­MYC expression and subsequent upregulation of lactate dehydrogenase A (LDHA) expression. Notably, gain­ and loss­of­function approaches revealed that LDHA overexpression in T47D cells enhanced migration and invasion by inducing EMT, while its depletion in SETDB1­overexpressing MCF7 cells reversed SETDB1­induced migration and invasion, as well as the Warburg effect and EMT. In conclusion, subcellular localization of cytoplasmic SETDB1 may be a pivotal factor in breast cancer progression. The present study offers valuable insight into the novel functions and mechanisms of cytoplasmic SETDB1.


Assuntos
Neoplasias da Mama , Domínios PR-SET , Feminino , Humanos , Neoplasias da Mama/patologia , Linhagem Celular Tumoral , Movimento Celular/genética , Citoplasma/metabolismo , Regulação Neoplásica da Expressão Gênica , Histona-Lisina N-Metiltransferase/genética , Histona-Lisina N-Metiltransferase/metabolismo , Lactato Desidrogenase 5/genética , Lactato Desidrogenase 5/metabolismo
2.
Materials (Basel) ; 16(9)2023 May 05.
Artigo em Inglês | MEDLINE | ID: mdl-37176431

RESUMO

Nonlinear ultrasonic guided waves have attracted increasing attention in the field of structural health monitoring due to their high sensitivity and long detection distance. In practical applications, the temperature of the tested structure will inevitably change, so it is essential to evaluate the effects of temperature on nonlinear ultrasonic guided waves. In this paper, an analytical approach is proposed to obtain the response law of nonlinear guided waves to temperature based on the semi-analytical finite element (SAFE) method. The plate structure is investigated as a demonstration example, and the corresponding simulation analysis and experimental verification are carried out. The results show that the variation trends of different cumulative second harmonic modes with temperature are distinct, and their amplitudes monotonically increase or decrease with the continuously rising temperature. Therefore, in the applications with nonlinear ultrasonic guided waves, it is necessary to predict the changing trend of selected cumulative second harmonics under the action of temperature and compensate the result for the influence of temperature. The methods and conclusions presented in this paper are also applicable to other types of structures and have general practicality.

4.
Int J Antimicrob Agents ; 61(5): 106793, 2023 May.
Artigo em Inglês | MEDLINE | ID: mdl-36933870

RESUMO

Mobile genetic elements (MGEs), such as integrative and conjugative elements (ICEs), plasmids and translocatable units (TUs), are important drivers for the spread of antibiotic resistance. Although ICEs have been reported to support the spread of plasmids among different bacteria, their role in mobilizing resistance plasmids and TUs has not yet been fully explored. In this study, a novel TU bearing optrA, a novel non-conjugative plasmid p5303-cfrD carrying cfr(D) and a new member of the ICESa2603 family, ICESg5301 were identified in streptococci. Polymerase chain reaction (PCR) assays revealed that three different types of cointegrates can be formed by IS1216E-mediated cointegration between the three different MGEs, including ICESg5301::p5303-cfrD::TU, ICESg5301::p5303-cfrD, and ICESg5301::TU. Conjugation assays showed that ICEs carrying p5303-cfrD and/or TU successfully transferred into recipient strains, thereby confirming that ICEs can serve as vectors for other non-conjugative MGEs, such as TUs and p5303-cfrD. As neither the TU nor plasmid p5303-cfrD can spread on their own between different bacteria, their integration into an ICE via IS1216E-mediated cointegrate formation not only increases the plasticity of ICEs, but also furthers the dissemination of plasmids and TUs carrying oxazolidinone resistance genes.


Assuntos
Conjugação Genética , Streptococcus , Plasmídeos/genética , Streptococcus/genética , Resistência Microbiana a Medicamentos , Transferência Genética Horizontal
5.
J Antimicrob Chemother ; 77(8): 2125-2129, 2022 07 28.
Artigo em Inglês | MEDLINE | ID: mdl-35640656

RESUMO

OBJECTIVES: To characterize the oxazolidinone resistance gene poxtA in a Lactobacillus salivarius isolate of pig origin. METHODS: L. salivarius isolate BNS11 was investigated for the presence of mobile oxazolidinone resistance genes by PCR. Antimicrobial susceptibility testing was performed by broth microdilution. Transfer experiments were conducted to assess horizontal transferability of the gene poxtA. WGS was carried out using a combination of Oxford Nanopore MinION/Illumina HiSeq platforms. The presence of translocatable units (TUs) carrying resistance genes was studied by PCR assays and subsequent sequence analysis. RESULTS: L. salivarius isolate BNS11 was positive for poxtA. WGS showed that it harboured two gene copies each of the poxtA and the fexB genes, which were located on the broad-host-range Inc18 plasmid pBNS11-37kb and in the chromosomal DNA, respectively. The plasmid-borne poxtA gene together with the genes fexB, vat(E) and erm(C) were located in an MDR region on plasmid pBNS11-37kb. Analysis of the genetic context showed that an approx. 11 kb poxtA-fexB fragment was integrated into the chromosomal DNA and two novel IS elements ISLasa1 and ISLasa2 were identified in this inserted fragment. PCR assays revealed that five different IS1216E-based TUs carrying the resistance genes poxtA, fexB, vat(E) or erm(C) were formed. CONCLUSIONS: To the best of our knowledge, this is the first report of the transferable oxazolidinone resistance gene poxtA in the genus Lactobacillus. In addition, the presence of IS1216E-based TUs will contribute to the persistence and accelerate the dissemination of resistance genes, including poxtA.


Assuntos
Ligilactobacillus salivarius , Oxazolidinonas , Animais , Antibacterianos/farmacologia , Farmacorresistência Bacteriana/genética , Genes Bacterianos , Ligilactobacillus salivarius/genética , Testes de Sensibilidade Microbiana , Oxazolidinonas/farmacologia , Plasmídeos/genética , Suínos , Resistência a Tetraciclina/genética
6.
Front Genet ; 13: 878658, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35432487

RESUMO

As a key element of the tumor microenvironment (TME), immune cell infiltration (ICI) is a frequently observed histologic finding in people with triple-negative breast cancer (TNBC), and it is linked to immunotherapy sensitivity. Nonetheless, the ICI in TNBC, to the best of our knowledge, has not been comprehensively characterized. In our current work, computational algorithms based on biological data from next-generation sequencing were employed to characterize ICI in a large cohort of TNBC patients. We defined various ICI patterns by unsupervised clustering and constructed the ICI scores using the principal component analysis (PCA). We observed patients with different clustering patterns had distinct ICI profiles and different signatures of differentially expressed genes. Patients with a high ICI score tended to have an increased PD-L1 expression and improved outcomes, and these patients were associated with decreased tumor mutational burden (TMB). Interestingly, it was showed that patients with high TMB exhibited an ameliorated overall survival (OS) than patients with low TMB. Furthermore, TMB scores only affected the prognosis of TNBC patients in the low-ICI score group but not in the high group. Finally, we identified a new immune-related lncRNA (irlncRNA) signature and established a risk model for the TNBC prognosis prediction. In addition, the high-risk group was related to poor prognosis, a high infiltration level of plasma B cells, monocytes, M2 macrophages, and neutrophils and a low PD-L1 expression. Therefore, the characterization and systematic evaluation of ICI patterns might potentially predict the prognosis and immunotherapy response in TNBC patients.

7.
J Vis Exp ; (179)2022 01 19.
Artigo em Inglês | MEDLINE | ID: mdl-35129168

RESUMO

Acute myocardial infarction is a common cardiovascular disease with high mortality. Myocardial reperfusion injury can counteract the beneficial effects of heart reflow and induce secondary myocardial injury. A simple and reproducible model of myocardial infarction and myocardial ischemia-reperfusion injury is a good tool for researchers. Here, a customizable method to create a myocardial infarction (MI) model and MIRI by precision ligation of the left anterior descending coronary artery (LAD) through micromanipulation is described. Accurate and reproducible ligature positioning of the LAD helps obtain consistent results for heart injury. ST-segment changes can help to identify model accuracy. The serum level of cardiac troponin T (cTnT) is used to assess the myocardial injury, cardiac ultrasound is employed to evaluate the myocardial systolic function, and Evans-Blue/triphenyl tetrazolium chloride staining is used to measure infarct size. In general, this protocol reduces procedure duration, ensures controllable infarct size, and improves mouse survival.


Assuntos
Infarto do Miocárdio , Traumatismo por Reperfusão Miocárdica , Animais , Coração , Camundongos , Traumatismo por Reperfusão Miocárdica/diagnóstico por imagem , Miocárdio , Troponina T
8.
J Antimicrob Chemother ; 77(4): 921-925, 2022 03 31.
Artigo em Inglês | MEDLINE | ID: mdl-35038329

RESUMO

OBJECTIVES: To investigate the genetic context and transferability of the oxazolidinone resistance genes cfr(D) and optrA in a porcine Vagococcus lutrae isolate. METHODS: V. lutrae isolate BN31 was screened for the presence of known oxazolidinone resistance genes via PCR assays. Conjugation experiments were carried out to assess horizontal transferability of resistance genes. WGS was performed using a combination of Nanopore MinION and Illumina HiSeq platforms. Detection of a translocatable unit (TU) was conducted by PCR. RESULTS: V. lutrae isolate BN31 harboured the oxazolidinone resistance genes cfr(D) and optrA. The optrA gene, together with the phenicol resistance gene fexA, was located on a novel pseudo-compound transposon, designated Tn7363. Tn7363 was bounded by two copies of the new insertion sequence ISVlu1, which represented a new member of the ISL3 family. A TU, comprising one copy of ISVlu1 and the segment between the two IS elements including the optrA gene, was detected. The cfr(D) gene and an erm(B) gene were identified on the broad-host-range Inc18 plasmid pBN31-cfrD, a pAMß1-like plasmid. Similar to plasmid pAMß1, plasmid pBN31-cfrD was conjugative. CONCLUSIONS: To the best of our knowledge, we report the first identification of the cfr(D) and optrA in Vagococcus. Two novel oxazolidinone resistance gene-carrying mobile genetic elements, Tn7363 and pBN31-cfrD, were identified in V. lutrae BN31. Considering their transmission potential, attention should be paid to the risk of transfer of the optrA and cfr(D) genes from V. lutrae to clinically more important bacterial pathogens.


Assuntos
Farmacorresistência Bacteriana , Enterococcus faecalis , Animais , Antibacterianos/farmacologia , Farmacorresistência Bacteriana/genética , Enterococcaceae , Genes Bacterianos , Testes de Sensibilidade Microbiana , Plasmídeos/genética , Suínos
9.
Vet Microbiol ; 266: 109340, 2022 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-35033843

RESUMO

The occurrence and dissemination of linezolid-resistant Gram-positive bacteria among food-producing animals poses severe threats to public health. To date, information about the emergence of the oxazolidinone resistance gene optrA in isolates from goats is scare. In this study, the optrA-positive multiresistant E. faecalis strain SY-1 was isolated from a goat in China. E. faecalis strain SY-1 displayed a multidrug resistance profile for most of antimicrobial agents tested, including linezolid and tedizolid. MLST analysis showed that E. faecalis strain SY-1 belonged to the high-risk clone ST16. Whole genome sequencing analysis revealed that the optrA gene together with several other resistance genes was located on a novel RepA_N-family plasmid pSY-1-optrA. Detailed sequence analysis indicated that pSY-1-optrA exhibited a mosaic structure that may be the result of recombination events. In addition, a mobile bacitracin resistance operon bcrABDR was identified on plasmid pSY-1-optrA. In conclusion, this is, to our knowledge, the first report of the optrA gene in the high-risk clone E. faecalis ST16 of goat origin. Active surveillance of optrA-positive E. faecalis high-risk clones in food-producing animals is urgently warranted.


Assuntos
Doenças das Cabras , Infecções por Bactérias Gram-Positivas , Oxazolidinonas , Animais , Antibacterianos/farmacologia , Células Clonais , Farmacorresistência Bacteriana/genética , Enterococcus faecalis , Cabras , Infecções por Bactérias Gram-Positivas/microbiologia , Infecções por Bactérias Gram-Positivas/veterinária , Interleucinas , Testes de Sensibilidade Microbiana/veterinária , Tipagem de Sequências Multilocus/veterinária , Plasmídeos/genética
10.
Sheng Wu Gong Cheng Xue Bao ; 37(11): 3828-3835, 2021 Nov 25.
Artigo em Chinês | MEDLINE | ID: mdl-34841788

RESUMO

Psoriasis is considered as an inflammatory disease driven by T cells, and its pathogenesis is closely related to the imbalance of intestinal bacteria flora. It has been reported that Bacteroides fragilis could play an anti-inflammatory role by regulating the expression of cytokines in T cells. To date, there is no report using B. fragilis to treat psoriasis. In this study, we explored the therapeutic effect of B. fragilis BF839 on psoriasis. We selected 27 psoriasis patients who were treated in the Second Affiliated Hospital of Guangzhou Medical University from April to October 2019. The patients were given B. fragilis BF839 orally for 12 weeks while maintaining the original treatment. The psoriasis area and severity index (PASI) score was evaluated before and after the treatment. The rate of drug withdrawal and reduction after 12 weeks of treatment were calculated. Our results showed that the rate of 12-week trial completion was 96.3% (26/27). We used PASIN to define the proportion of people whose PASI score decreased more than or equal to N% after treatment. At 12 weeks, PASI30, PASI50, and PASI75 were 65.4%, 42.3%, and 19.2%, respectively. The PASI score was 9.1±5.9 and 5.8±4.9 before and after 12 weeks of treatment respectively, and the difference was statistically significant (P<0.01). The effective rate of the visual analog scale (VAS) score was 42.3% at 12 weeks, and the VAS score was 2.9±2.2 and 2.3±2.1 before and after 12 weeks of treatment, respectively, which had no statistically significant difference (P>0.05). The adverse reaction rate of patients was 3.8% (1/26) within 12 weeks of treatment, including 1 case of constipation, and the rate of drug withdrawal and reduction was 60.0%. The above results suggest that B. fragilis BF839 may be functional on the treatment of psoriasis by reducing the PASI score and the drug usage rate with few side effect, which deserves further study.


Assuntos
Bacteroides fragilis , Psoríase , Anti-Inflamatórios , Citocinas , Humanos , Psoríase/tratamento farmacológico , Índice de Gravidade de Doença , Resultado do Tratamento
12.
Front Immunol ; 12: 732933, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34707607

RESUMO

Autoimmune diseases are a broad spectrum of human diseases that are characterized by the breakdown of immune tolerance and the production of autoantibodies. Recently, dysfunction of innate and adaptive immunity is considered to be a key step in the initiation and maintenance of autoimmune diseases. NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome is a multimeric protein complex, which can detect exogenous pathogen irritants and endogenous danger signals. The main function of NLRP3 inflammasome is to promote secretion of interleukin (IL)-1ß and IL-18, and pyroptosis mediated by caspase-1. Served as a checkpoint in innate and adaptive immunity, aberrant activation and regulation of NLRP3 inflammasome plays an important role in the pathogenesis of autoimmune diseases. This paper reviewed the roles of NLRP3 inflammasome in autoimmune diseases, which shows NLRP3 inflammasome may be a potential target for autoimmune diseases deserved further study.


Assuntos
Imunidade Adaptativa , Doenças Autoimunes/imunologia , Autoimunidade , Imunidade Inata , Inflamassomos/imunologia , Proteína 3 que Contém Domínio de Pirina da Família NLR/imunologia , Imunidade Adaptativa/efeitos dos fármacos , Animais , Anti-Inflamatórios/uso terapêutico , Doenças Autoimunes/tratamento farmacológico , Doenças Autoimunes/metabolismo , Autoimunidade/efeitos dos fármacos , Humanos , Imunidade Inata/efeitos dos fármacos , Inflamassomos/antagonistas & inibidores , Inflamassomos/metabolismo , Proteína 3 que Contém Domínio de Pirina da Família NLR/antagonistas & inibidores , Proteína 3 que Contém Domínio de Pirina da Família NLR/metabolismo , Transdução de Sinais
15.
Vet Microbiol ; 257: 109065, 2021 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-33866063

RESUMO

Tetracyclines are the broad-spectrum agents used in veterinary medicine and food animal production. Known mechanisms of tetracycline resistance include ribosome protection, active efflux and enzymatic inactivation. However, the presence of two different tet genes conferring different resistance mechanisms on the same plasmid has rarely been reported. In this study, we identified the tandem tetracycline resistance genes tet(61)-tet(58) on the novel plasmid pT4303. These tet genes were identified for the first time in Aerococcus urinaeequi. Reduced susceptibility to doxycycline was observed in S. aureus RN4220 harboring tet(61) when an extra tet(58) was expressed. Plasmid pT4303 was electrotransformed into S. aureus RN4220, E. faecalis JH2-2, S. suis BAA and E. coli DH5α and conferred tetracycline resistance (MIC ≥ 16) in both Gram-positive and Gram-negative bacteria, assuming that it might serve as a vehicle for the dissemination of the tetracycline resistance genes tet(61) and tet(58).


Assuntos
Aerococcus/genética , Genes Bacterianos , Plasmídeos/genética , Resistência a Tetraciclina/genética , Aerococcus/efeitos dos fármacos , Aerococcus/isolamento & purificação , Animais , Antibacterianos/farmacologia , Genoma Bacteriano , Bactérias Gram-Negativas/efeitos dos fármacos , Bactérias Gram-Negativas/genética , Bactérias Gram-Positivas/efeitos dos fármacos , Bactérias Gram-Positivas/genética , Testes de Sensibilidade Microbiana , Plasmídeos/isolamento & purificação , Suínos , Tetraciclinas/farmacologia , Sequenciamento Completo do Genoma
16.
Sensors (Basel) ; 21(9)2021 Apr 28.
Artigo em Inglês | MEDLINE | ID: mdl-33924925

RESUMO

The seam tracking operation is essential for extracting welding seam characteristics which can instruct the motion of a welding robot along the welding seam path. The chief tasks for seam tracking would be divided into three partitions. First, starting and ending points detection, then, weld edge detection, followed by joint width measurement, and, lastly, welding path position determination with respect to welding robot co-ordinate frame. A novel seam tracking technique with a four-step method is introduced. A laser sensor is used to scan grooves to obtain profile data, and the data are processed by a filtering algorithm to smooth the noise. The second derivative algorithm is proposed to initially position the feature points, and then linear fitting is performed to achieve precise positioning. The groove data are transformed into the robot's welding path through sensor pose calibration, which could realize real-time seam tracking. Experimental demonstration was carried out to verify the tracking effect of both straight and curved welding seams. Results show that the average deviations in the X direction are about 0.628 mm and 0.736 mm during the initial positioning of feature points. After precise positioning, the average deviations are reduced to 0.387 mm and 0.429 mm. These promising results show that the tracking errors are decreased by up to 38.38% and 41.71%, respectively. Moreover, the average deviations in both X and Z direction of both straight and curved welding seams are no more than 0.5 mm, after precise positioning. Therefore, the proposed seam tracking method with four steps is feasible and effective, and provides a reference for future seam tracking research.

18.
Stem Cell Res ; 51: 102213, 2021 03.
Artigo em Inglês | MEDLINE | ID: mdl-33556917

RESUMO

Netherton syndrome (NS) is a rare, autosomal recessive hereditary skin disease caused by mutations in SPINK5 gene, characterized with severe skin barrier damage. A human induced pluripotent stem cell (iPSC) line has been established with electroporation method from urine-derived cells of a NS patient carrying a compound heterozygous mutation c.2260A > T (p.K754X) and c.2423C > T(p.T808I) in SPINK5 gene. This iPSC line may serve as a valuable model for the research of pathogenesis of NS, and the mechanisms and therapeutics for skin barrier damage.


Assuntos
Células-Tronco Pluripotentes Induzidas , Síndrome de Netherton , Humanos , Mutação , Síndrome de Netherton/genética , Proteínas Secretadas Inibidoras de Proteinases/genética , Inibidor de Serinopeptidase do Tipo Kazal 5/genética
19.
Med Sci Monit ; 26: e922982, 2020 Apr 19.
Artigo em Inglês | MEDLINE | ID: mdl-32305991

RESUMO

BACKGROUND SETDB1, an H3K9-specific histone methyltransferase, plays important roles in the progression of various human cancers. However, the expression patterns and its clinical roles of SETDB1 remain elusive in breast cancer (BC). MATERIAL AND METHODS The transcriptional level of SETDB1 and survival data in BC were analyzed through UALCAN, ONCOMINE, and Pan Cancer Prognostics Database. SETDB1 protein expression was assessed by immunohistochemistry (IHC) in 159 BC tissue samples. The associations between SETDB1 expression and clinical pathological characteristics of patients were analyzed. The GEO dataset GSE108656 was downloaded and analyzed to identify the differentially expressed genes (DEGs) between control and BC cells targeting interference with SETDB. The DEGs were further integrated by bioinformatics analysis to decipher the key signaling pathways and hub genes that are regulated by SETDB. RESULTS The public databases showed the level of SETDB1 mRNA was significantly upregulated in BC. Our IHC results demonstrated the level of SETDB1 protein was associated with tumor size (P=0.028), histopathological grading (P=0.012), lymph node metastasis (P<0.001), and TNM stage (P<0.001). High expression of SETDB1 indicated worse overall survival (P=0.015) and shorter relapse-free survival (P=0.027). The bioinformatic analysis of GSE108656 suggested that the SETDB1-related DEGs was mainly enriched in antigen processing and presentation, as well as immune networks in BC. The cytoHubba analysis suggested the top 10 hub genes were IL6, BMP4, CD74, PECAM1, HLA-DPA1, HLA-DRA, LAMC1, CTSB, SERPINA1, and CTSD. CONCLUSIONS The results suggest that SETDB1 is an oncogene and can serve as a prognostic biomarker for BC. However, the mechanisms of SETDB1 in BC remain to be explored.


Assuntos
Neoplasias da Mama/genética , Histona-Lisina N-Metiltransferase/genética , Biomarcadores Tumorais/genética , Neoplasias da Mama/metabolismo , Biologia Computacional/métodos , Bases de Dados Genéticas , Feminino , Expressão Gênica/genética , Perfilação da Expressão Gênica/métodos , Regulação Neoplásica da Expressão Gênica/genética , Ontologia Genética , Redes Reguladoras de Genes , Histona Metiltransferases/genética , Histona-Lisina N-Metiltransferase/metabolismo , Humanos , Recidiva Local de Neoplasia/genética , Oncogenes , Prognóstico , RNA Mensageiro , Transcriptoma/genética
20.
Oncol Rep ; 41(2): 1284-1292, 2019 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-30483750

RESUMO

SET domain bifurcated 1 (SETDB1) is a histone H3 lysine 9 methyltransferase that is highly expressed in various tumor types, including breast cancer. However, how SETDB1 functions in breast cancer is unclear. In the present study, proliferation, migration and invasion assays were performed to explore the role of SETDB1 in breast cancer cells. SETDB1 downregulation in BT549 and MDA­MB­231 cells reduced cell proliferation, whereas upregulation in MCF7 and T47D cells enhanced proliferation. Depletion of SETDB1 suppressed cell migration and invasion in vitro and reduced lung metastasis in vivo. By contrast, SETDB1 overexpression enhanced cell migration and invasiveness. Notably, SETDB1 overexpression appeared to induce epithelial­mesenchymal transition (EMT) in MCF7 cells. Mechanistic investigations indicated that SETDB1 acts as an EMT inducer by binding directly to the promoter of the transcription factor Snail. Thus, SETDB1 is involved in breast cancer metastasis and may be a therapeutic target for treating patients with breast cancer.


Assuntos
Neoplasias da Mama/genética , Neoplasias da Mama/patologia , Proteínas de Transporte/metabolismo , Transição Epitelial-Mesenquimal/genética , Regulação Neoplásica da Expressão Gênica , Proteínas Nucleares/metabolismo , Fatores de Transcrição da Família Snail/genética , Neoplasias da Mama/metabolismo , Proteínas de Transporte/genética , Movimento Celular/genética , Proliferação de Células/genética , Regulação para Baixo , Feminino , Humanos , Células MCF-7 , Invasividade Neoplásica , Proteínas Nucleares/genética , Regiões Promotoras Genéticas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA